68 Participants Needed

Inspiratory Muscle Training for Heart Failure

JS
EB
Overseen ByEric Bruhn, M.A.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
Must be taking: SGLT2 inhibitors, Spironolactone
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how a specific breathing exercise, called inspiratory muscle training, can help people with heart failure improve their breathing during exercise. Participants will perform this exercise at either high or very low intensity for comparison. Individuals experiencing heart failure symptoms, taking specific heart failure medications, and able to exercise without major physical limitations might be suitable for this trial.

As an unphased trial, this study provides a unique opportunity to contribute to understanding innovative approaches to managing heart failure symptoms.

Do I need to stop my current medications for the trial?

The trial requires participants to have been taking SGLT2 inhibitors and spironolactone (and beta-blockers for certain patients) for more than 3 months, so you will need to continue these medications. The protocol does not specify if you need to stop any other medications.

What prior data suggests that inspiratory muscle training is safe for heart failure patients?

Research has shown that Inspiratory Muscle Training (IMT) is generally safe for people with heart failure. Studies have found that IMT can improve breathing and increase exercise capacity without causing serious side effects. People with chronic heart failure who used IMT reported easier exercise and felt less tired and out of breath.

Additionally, no major negative effects have been commonly linked to IMT, indicating that patients tolerate it well. Those considering joining a trial should discuss any concerns with their healthcare provider.12345

Why are researchers excited about this trial?

Inspiratory Muscle Training (IMT) is unique because it strengthens the muscles used for breathing, unlike traditional heart failure treatments that focus on medications like ACE inhibitors, beta-blockers, or diuretics to manage symptoms and improve heart function. Researchers are excited about IMT because it directly enhances respiratory muscle strength, potentially improving patient endurance and quality of life. This non-drug approach offers a promising complementary option to existing therapies, addressing a different aspect of heart failure management by focusing on breathing efficiency.

What evidence suggests that inspiratory muscle training is effective for heart failure?

Research has shown that inspiratory muscle training (IMT) can help people with heart failure. In this trial, participants will divide into two groups: one receiving IMT at 40% maximal inspiratory pressure and another receiving a sham treatment at 2% maximal inspiratory pressure. Studies have found that IMT strengthens breathing muscles and improves the quality of life for these patients. It also lowers certain heart-related markers, indicating better heart health. Other research suggests that IMT improves blood flow to both resting and active limbs in people with chronic heart failure, potentially aiding circulation during physical activity. Overall, promising evidence indicates that IMT can benefit heart failure patients.678910

Who Is on the Research Team?

JS

Joshua Smith, PhD

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

This trial is for adults over 18 with heart failure who can exercise, have a BMI ≤40 kg/m2, and are non-smokers or have quit smoking with less than a 20 pack-year history. They must be on certain heart medications for more than 3 months. Pregnant women, current heavy smokers, those with severe asthma or liver issues, and individuals with recent serious heart rhythm problems cannot join.

Inclusion Criteria

Able to exercise (i.e. without significant orthopedic limitations or musculoskeletal disorders limiting their ability to exercise)
I have been on SGLT2 inhibitors and spironolactone for over 3 months.
Body mass index ≤40 kg/m2
See 2 more

Exclusion Criteria

Pregnant women (testing will be done by research team if requested)
I have asthma with severe attacks and don't always notice when my breathing is bad.
I currently smoke or have smoked more than 20 pack-years.
See 11 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo inspiratory muscle training at specified intensities for 8 weeks

8 weeks
7 sessions per week

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Inspiratory Muscle Training
Trial Overview The study tests how training the muscles used for breathing affects their function during exercise in patients with heart failure. Participants will undergo inspiratory muscle training to see if it improves their ability to breathe when active.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Inspiratory muscle training (IMT) groupExperimental Treatment1 Intervention
Group II: SHAM groupPlacebo Group1 Intervention

Inspiratory Muscle Training is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Inspiratory Muscle Training for:
🇺🇸
Approved in United States as Inspiratory Muscle Training for:
🇨🇦
Approved in Canada as Inspiratory Muscle Training for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Published Research Related to This Trial

A study involving 40 critically ill patients showed that using an electronic device for inspiratory muscle training (IMT) was feasible, with 81% of planned sessions completed, indicating good adherence to the intervention.
The electronic IMT was found to be safe, with no major adverse events and only 10% minor adverse events that were transient and without clinical consequences, while over 85% of participants reported it as helpful for their recovery.
Feasibility, safety, and patient acceptability of electronic inspiratory muscle training in patients who require prolonged mechanical ventilation in the intensive care unit: A dual-centre observational study.Nickels, M., Erwin, K., McMurray, G., et al.[2023]
Inspiratory muscle training (IMT) significantly improved inspiratory strength and endurance in patients with chronic heart failure (CHF), as evidenced by increased maximum inspiratory pressure and sustained maximal inspiratory pressure after 10 weeks of training.
Patients undergoing IMT also experienced enhanced exercise capacity, reduced dyspnea, and improved quality of life, demonstrating the efficacy of this intervention in managing symptoms of CHF.
Inspiratory muscle training using an incremental endurance test alleviates dyspnea and improves functional status in patients with chronic heart failure.Laoutaris, I., Dritsas, A., Brown, MD., et al.[2019]
High-intensity inspiratory muscle training (HIIMT) significantly improves exercise capacity and respiratory muscle strength in patients with heart failure with reduced ejection fraction (HFrEF), based on a review of five studies involving 138 patients.
HIIMT led to measurable improvements in VO2peak, walking tests, and maximal inspiratory pressure, indicating its efficacy as a beneficial intervention for this patient population.
The impact of high-intensity inspiratory muscle training on exercise capacity and inspiratory muscle strength in heart failure with reduced ejection fraction: a systematic review and meta-analysis.Gomes Neto, M., Ferrari, F., Helal, L., et al.[2019]

Citations

Inspiratory Muscle Training in Patients with Heart FailureINTRODUCTION. Chronic heart failure (CHF) is a clinical condition where the heart is unable to provide adequate tissue perfusion, especially to the vital organs ...
The efficacy of inspiratory muscle training in improving ...Conclusion. IMT significantly improved respiratory muscle strength, QoL, and reduced cardiac biomarker levels in patients with both heart failure with preserved ...
The efficacy of inspiratory muscle training in improving ...Conclusion. IMT significantly improved respiratory muscle strength, QoL, and reduced cardiac biomarker levels in patients with both heart failure with preserved ...
The efficacy of inspiratory muscle training in patients with ...Inspiratory muscle training improves blood flow to resting and exercising limbs in patients with chronic heart failure. J Am Coll Cardiol. 2008; ...
Effect of inspiratory muscle training in patients with chronic ...Background: The effect of inspiratory muscle training (IMT) in chronic heart failure (CHF) patients remains unclear now.
Inspiratory Muscle Training in Patients With Heart Failure ...Most patients with chronic heart failure (CHF) are limited in their physical activity by fatigue and dyspnea, and it has been suggested that respiratory muscle ...
Effectiveness and safety of inspiratory muscle training in ...Left heart or lung disease is the most common cause of PH. PH-induced decrease in pulmonary vasculature distensibility leads to a marked ...
8.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/32936904/
Inspiratory Muscle Training in Patients With Heart FailureFor people with heart failure, IMT by itself, without being combined with other exercise, can improve ease of breathing, increase the amount ...
Inspiratory Muscle Training in Hospitalized Heart Failure ...Effects of Inspiratory Muscle Training on Inspiratory Muscle Strength in Hospitalized Heart Failure Patients: A Randomized Clinical Trial.
Inspiratory Muscle Training Intensity in Patients Living with ...According to Chiappa et al. (2008), IMT enhances functional capacity of patients with chronic heart failure [3]. The same authors concluded that ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security